Name: UMIN ID:
Unique ID issued by UMIN | C000000091 |
---|---|
Receipt number | R000000133 |
Scientific Title | The Japan Working Group for the Assessment That the Pioglitazone Protects DM Patients Against Re-Infarction |
Date of disclosure of the study information | 2005/08/31 |
Last modified on | 2020/03/09 10:08:53 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2005/08/29 21:13:50 | ||
2 | Update | 2009/12/22 22:05:28 | Key inclusion criteria Key inclusion criteria Target sample size |
|
3 | Update | 2009/12/22 22:06:03 | Recruitment status Last follow-up date |
|
4 | Update | 2012/09/20 10:56:28 | Last follow-up date |
|
5 | Update | 2012/09/21 13:54:45 | Name of person sending information Organization Division name Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
6 | Update | 2016/09/06 09:36:56 | Email Last name of contact person Last name of contact person Address Address Name of primary person or sponsor Organization |
|
7 | Update | 2016/09/06 09:38:43 | Randomization unit Stratification Dynamic allocation Institution consideration Blocking Concealment |
|
8 | Update | 2018/05/22 10:39:19 | Interventions/Control_1 Interventions/Control_1 |
|
9 | Update | 2018/05/22 10:41:29 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
10 | Update | 2018/05/22 10:44:14 | Organization Organization Division name Division name Institute Institute Department |
|
11 | Update | 2018/05/22 11:03:36 | Condition Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
12 | Update | 2020/03/09 09:35:21 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
13 | Update | 2020/03/09 09:54:28 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
14 | Update | 2020/03/09 10:06:19 | Organization Organization |
|
15 | Update | 2020/03/09 10:08:28 | Recruitment status Date of IRB |
|
16 | Update | 2020/03/09 10:08:53 | Publication of results |